- Home
- CRBP vs ALAR Comparison
CRBP vs ALAR Comparison
Compare CRBP & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- ALAR
- Stock Information
- Founded
- CRBP 2009
- ALAR 2013
- Country
- CRBP United States
- ALAR Israel
- Employees
- CRBP N/A
- ALAR N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- ALAR Computer Software: Prepackaged Software
- Sector
- CRBP Health Care
- ALAR Technology
- Exchange
- CRBP Nasdaq
- ALAR Nasdaq
- Market Cap
- CRBP 110.3M
- ALAR 116.1M
- IPO Year
- CRBP N/A
- ALAR 2018
- Fundamental
- Price
- CRBP $9.79
- ALAR $16.55
- Analyst Decision
- CRBP Strong Buy
- ALAR Strong Buy
- Analyst Count
- CRBP 10
- ALAR 1
- Target Price
- CRBP $53.22
- ALAR $15.00
- AVG Volume (30 Days)
- CRBP 107.9K
- ALAR 90.6K
- Earning Date
- CRBP 08-05-2025
- ALAR 08-28-2025
- Dividend Yield
- CRBP N/A
- ALAR N/A
- EPS Growth
- CRBP N/A
- ALAR N/A
- EPS
- CRBP N/A
- ALAR 0.07
- Revenue
- CRBP N/A
- ALAR $30,581,000.00
- Revenue This Year
- CRBP N/A
- ALAR $11.54
- Revenue Next Year
- CRBP $270.04
- ALAR $19.42
- P/E Ratio
- CRBP N/A
- ALAR $24.57
- Revenue Growth
- CRBP N/A
- ALAR 4.67
- 52 Week Low
- CRBP $4.64
- ALAR $5.45
- 52 Week High
- CRBP $61.89
- ALAR $22.44
- Technical
- Relative Strength Index (RSI)
- CRBP 62.32
- ALAR 66.68
- Support Level
- CRBP $8.88
- ALAR $15.65
- Resistance Level
- CRBP $9.59
- ALAR $17.27
- Average True Range (ATR)
- CRBP 0.59
- ALAR 0.92
- MACD
- CRBP 0.03
- ALAR 0.11
- Stochastic Oscillator
- CRBP 78.45
- ALAR 83.56
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.